Oligomerization transforms human APOBEC3G from an efficient enzyme to a slowly dissociating nucleic acid-binding protein

Nature Chemistry

Volumn 6, Issue 1, 2014, Pages 28-33

  Chaurasiya, Kathy R ^a   McCauley, Micah J ^a   Wang, Wei ^b   Qualley, Dominic F ^b   Wu, Tiyun ^c   Kitamura, Shingo ^d   Geertsema, Hylkje ^a   Chan, Denise S B ^e   Hertz, Amber ^c   Iwatani, Yasumasa ^c,d   Levin, Judith G ^c   Musier Forsyth, Karin ^b   Rouzina, Ioulia ^f   Williams, Mark C ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOBEC3G PROTEIN, HUMAN; BIOPOLYMER; CYTIDINE DEAMINASE; RNA DIRECTED DNA POLYMERASE;

CHEMISTRY; DEAMINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; PHYSIOLOGY; VIRUS REPLICATION; ARTICLE;

BIOPOLYMERS; CYTIDINE DEAMINASE; DEAMINATION; HIV-1; HUMANS; RNA-DIRECTED DNA POLYMERASE; VIRUS REPLICATION;

EID: 84890919129     PISSN: 17554330     EISSN: 17554349     Source Type: Journal    
DOI: 10.1038/nchem.1795     Document Type: Article

References (48)

1. Malim, M. H. APOBEC proteins and intrinsic resistance to HIV-1 infection. Philos. Trans. R. Soc. Lond. B 364, 675-687(2009).
2. Harris, R. S. & Liddament, M. T. Retroviral restriction by APOBEC proteins. Nature Rev. Immunol. 4, 868-877(2004). (Pubitemid 39490762)
3. Duggal, N. K. & Emerman, M. Evolutionary conflicts between viruses and restriction factors shape immunity. Nature Rev. Immunol. 12, 687-695(2012).
4. Chiu, Y. L. & Greene, W. C. The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu. Rev. Immunol. 26, 317-353(2008). (Pubitemid 351600379)
5. Sheehy, A. M., Gaddis, N. C., Choi, J. D. & Malim, M. H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418, 646-650(2002).
6. Holmes, R. K., Malim, M. H. & Bishop, K. N. APOBEC-mediated viral restriction: not simply editing? Trends Biochem. Sci. 32, 118-128(2007). (Pubitemid 46367691)
7. Fisher, A. G. et al. The sor gene of HIV-1 is required for efficient virus transmission in vitro. Science 237, 888-893(1987). (Pubitemid 17128277)
8. Strebel, K. et al. The HIV 'A' (sor) gene product is essential for virus infectivity. Nature 328, 728-730(1987). (Pubitemid 17125778)
9. Goila-Gaur, R. & Strebel, K. HIV-1 Vif, APOBEC, and intrinsic immunity. Retrovirology 5, 1-16(2008).
10. Lecossier, D., Bouchonnet, F., Clavel, F. & Hance, A. J. Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science 300, 1112(2003). (Pubitemid 36583087)
11. Mangeat, B. et al. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424, 99-103(2003). (Pubitemid 36834849)
12. Zhang, H. et al. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424, 94-98(2003). (Pubitemid 36834848)
13. Suspène, R. et al. APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase. Nucleic Acids Res. 32, 2421-2429(2004). (Pubitemid 38854796)
14. Yu, Q. et al. Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome. Nature Struct. Mol. Biol. 11, 435-442(2004). (Pubitemid 38568947)
15. Harris, R. S. et al. DNA deamination mediates innate immunity to retroviral infection. Cell 113, 803-809(2003); erratum 116, 629(2004). (Pubitemid 36724943)
16. Levin, J. G., Mitra, M., Mascarenhas, A. & Musier-Forsyth, K. Role of HIV-1 nucleocapsid protein in HIV-1 reverse transcription. RNA Biol. 7, 754-774(2010).
17. Newman, E. N. C. et al. Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity. Curr. Biol. 15, 166-170(2005).
18. Holmes, R. K., Koning, F. A., Bishop, K. N. & Malim, M. H. APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation - comparisons with APOBEC3G. J. Biol. Chem. 282, 2587-2595(2007). (Pubitemid 47076764)
19. Iwatani, Y., Takeuchi, H., Strebel, K. & Levin, J. G. Biochemical activities of highly purified, catalytically active human APOBEC3G: correlation with antiviral effect. J. Virol. 80, 5992-6002(2006). (Pubitemid 43849177)
20. Luo, K. et al. Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation. J .Virol. 81, 7238-7248(2007). (Pubitemid 46986660)
21. Turelli, P., Mangeat, B., Jost, S., Vianin, S. & Trono, D. Inhibition of hepatitis B virus replication by APOBEC3G. Science 303, 1829(2004). (Pubitemid 38374868)
22. Bogerd, H. P., Wiegand, H. L., Doehle, B. P., Lueders, K. K. & Cullen, B. R. APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells. Nucleic Acids Res. 34, 89-95(2006). (Pubitemid 43167918)
23. Bogerd, H. P. et al. Cellular inhibitors of long interspersed element 1 and Alu retrotransposition. Proc. Natl Acad. Sci. USA 103, 8780-8785(2006). (Pubitemid 43878096)
24. Chen, H. et al. APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons. Curr. Biol. 16, 480-485(2006). (Pubitemid 43343708)
25. Muckenfuss, H. et al. APOBEC3 proteins inhibit human LINE-1 retrotransposition. J. Biol. Chem. 281, 22161-22172(2006). (Pubitemid 44181920)
26. Kinomoto, M. et al. All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition. Nucleic Acids Res. 35, 2955-2964(2007). (Pubitemid 47073634)
27. Niewiadomska, A. M. et al. Differential inhibition of long interspersed element 1 by APOBEC3 does not correlate with high-molecular-mass-complex formation or P-body association. J. Virol. 81, 9577-9583(2007). (Pubitemid 47311504)
28. Bulliard, Y. et al. Structure-function analyses point to a polynucleotideaccommodating groove essential for APOBEC3A restriction activities. J .Virol. 85, 1765-1776(2011).
29. Narvaiza, I. et al. Deaminase-independent inhibition of parvoviruses by the APOBEC3A cytidine deaminase. PLoS Pathog. 5, e1000439(2009).
30. Bishop, K. N., Verma, M., Kim, E. Y., Wolinsky, S. M. & Malim, M. H. APOBEC3G inhibits elongation of HIV-1 reverse transcripts. PLoS Pathog. 4, e1000231(2008).
31. Adolph, M. B., Webb, J. & Chelico, L. Retroviral restriction factor APOBEC3G delays the initiation of DNA synthesis by HIV-1 reverse transcriptase. Plos One 8, e64196(2013).
32. Iwatani, Y. et al. Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G. Nucleic Acids Res. 35, 7096-7108(2007).
33. Li, X. Y., Guo, F., Zhang, L. & Kleiman, L. & Cen S. APOBEC3G inhibits DNA strand transfer during HIV-1 reverse transcription. J. Biol. Chem. 282, 32065-32074(2007). (Pubitemid 350106412)
34. Mbisa, J. L. et al. Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration. J. Virol. 81, 7099-7110(2007). (Pubitemid 46986646)
35. Gillick, K. et al. Suppression of HIV-1 infection by APOBEC3 proteins in primary human CD4 T cells is associated with inhibition of processive reverse transcription as well as excessive cytidine deamination. J. Virol. 87, 1508-1517(2013).
36. Xu, H. Z. et al. Stoichiometry of the antiviral protein APOBEC3G in HIV-1 virions. Virology 360, 247-256(2007).
37. Chelico, L., Sacho, E. J., Erie, D. A. & Goodman, M. F. A model for oligomeric regulation of APOBEC3G cytosine deaminase-dependent restriction of HIV. J. Biol. Chem. 283, 13780-13791(2008).
38. Nowarski, R., Britan-Rosich, E., Shiloach, T. & Kotler, M. Hypermutation by intersegmental transfer of APOBEC3G cytidine deaminase. Nature Struct. Mol. Biol. 15, 1059-1066(2008).
39. King, G. A. et al. Revealing the competition between peeled ssDNA, melting bubbles, and S-DNA during DNA overstretching using fluorescence microscopy. Proc. Natl Acad. Sci. USA 110, 3859-3864(2013).
40. Chaurasiya, K. R., Paramanathan, T., McCauley, M. J. & Williams, M. C. Biophysical characterization of DNA binding from single molecule force measurements. Phys. Life Rev. 7, 299-341(2010).
41. Senavirathne, G. et al. Single-stranded DNA scanning and deamination by APOBEC3G cytidine deaminase at single molecule resolution. J. Biol. Chem. 287, 15826-15835(2012).
42. Chelico, L., Prochnow, C., Erie, D. A., Chen, X. S. & Goodman, M. F. Structural model for deoxycytidine deamination mechanisms of the HIV-1 inactivation enzyme APOBEC3G. J. Biol. Chem. 285, 16195-16205(2010).
43. Huthoff, H., Autore, F., Gallois-Montbrun, S., Fraternali, F. & Malim, M. H. RNA-dependent oligomerization of APOBEC3G is required for restriction of HIV-1. PLoS Pathog. 5, e1000330(2009).
44. Bélanger, K., Savoie, M., Rosales Gerpe, M. C., Couture, J-F. & Langlois, M-A. Binding of RNA by APOBEC3G controls deamination-independent restriction of retroviruses. Nucleic Acids Res. 41, 7438-7452(2013).
45. Soros, V. & Greene, W. APOBEC3G and HIV-1: strike and counterstrike. Curr. HIV/AIDS Rep. 4, 3-9(2007). (Pubitemid 46555245)
46. Wang, X. X. et al. The cellular antiviral protein APOBEC3G interacts with HIV- 1 reverse transcriptase and inhibits its function during viral replication. J. Virol. 86, 3777-3786(2012).
47. Coffin, J. M., Hughes, S. H. & Varmus, H. E. Retroviruses (Cold Spring Harbor Laboratory Press, 1997).
48. Vo, M. N., Barany, G., Rouzina, I. & Musier-Forsyth, K. Mechanistic studies of mini-TAR RNA/DNA annealing in the absence and presence of HIV-1 nucleocapsid protein. J. Mol. Biol. 363, 244-261(2006). (Pubitemid 44414853)